ELAN
Elanco Animal Health Inc
Elanco Animal Health Inc (ELAN) has 13 SEC Form 4 filings (21 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 9, 2026.
Insiders have net bought $200K over the trailing 6 months.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Jeffrey N. Simmons
- Employees:9,000
- HQ:Greenfield, IN, US
- IPO:2018-09-20
Insider Buying
$200K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$12.7B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Simmons Jeffrey NFirst filing | PRESIDENT, CEO AND DIRECTOR | Purchase | 4,971 | $100K | May 19 | SEC ↗ |
Modi Rajeev A.First filing | SEE REMARKS | Purchase | 4,911 | $100K | May 19 | SEC ↗ |
Related companies
Elanco Animal Health Inc is in the Healthcare sector.